Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Meredith_Fensom
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Meredith_Fensom
-
Meredith Fensom proslijedio/la je Tweet
Today is
#WorldCancerDay
. Join #Precigen as we strive to find new therapies for difficult-to-treat cancers. Together, we can advance medicine with precision in the pursuit of new treatment options.#IAmAndIWill
pic.twitter.com/21ysx9xgkgHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
“Thank you for saving my life." Tomas Dahl (pictured left) was diagnosed with tonsil cancer and told there was no cure. But after trying the cancer therapy pioneered by the 2018 Medicine Laureates (centre and right), he emerged cancer-free.
#WorldCancerDay
pic.twitter.com/vidR7zGKUr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
Congratulations to the
#Precigen team and our new shareholders for the start of a new chapter. We look forward to continuing to live by our brand promise to advance medicine with precision.$PGEN@nasdaq#Maryland#GeneTherapy#CellTherapy#Immunotherapy https://bit.ly/391JDLi pic.twitter.com/VhepwI0wLm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
#Precigen completes series of transactions to solidify healthcare focus$PGEN#Maryland#biopharma@nasdaq#GeneTherapy#CellTherapy#Immunotherapy https://prn.to/2SbVCiI pic.twitter.com/mpX9XYwbUe
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
Welcome
#Precigen investors to http://investors.precigen.com . This new site provides the latest updates on$PGEN and our progress as we advance medicine with precision.#Maryland#biopharma@nasdaq#GeneTherapy#CellTherapy#Immunotherapy https://bit.ly/391JDLi pic.twitter.com/DqHN6ibWyS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
ICER finalizes 2020-2023 Value Assessment Framework. Updates place stronger emphasis on real-world evidence, deliberation over broader contextual considerations, and patient engagement before/during/after each value assessment.https://icer-review.org/announcements/2020_vaf_update/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
Just published: results of Cornell University field studies with Oxitec's solution for diamondback moth, a widely insecticide-resistant pest damaging important food crops around the world https://www.frontiersin.org/article/10.3389/fbioe.2019.00482 …pic.twitter.com/1SeUXVM2vK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
Enjoying the opening remarks from Marty Rosendale at the
@MDTechCouncil Annual Leadership Dinner.pic.twitter.com/stWpYujkZo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
We are excited to start our luncheon on Emerging Opportunities in Addressing Healthcare Costs: The Role of Biosimilars with Robert Popovian, Vice President, US Government Relations with
@pfizerpic.twitter.com/Uauz7kxIrF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
Thank you
@MDTechCouncil for hosting the Annual Annapolis Day & Leadership Dinner.#Precigen enjoyed speaking with General Assembly Members about delivering innovative solutions to pressing healthcare challenges.#Biotechnology#CellTherapy#GeneTherapy#Maryland#MDGA20https://twitter.com/MDTechCouncil/status/1222518549622771713 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
Maryland’s innovation economy creates life-changing treatments for patients around the country. And the cutting-edge life sciences firms that call MD home create thousands of high paying jobs. Our members are in Annapolis today urging lawmakers to protect innovation.
#MDGA20pic.twitter.com/PXtviPmdfJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
#ICYMI - Precigen provides 2020 preclinical milestones during#JPM20 - an exciting year ahead for the company! http://bit.ly/30qy4ua pic.twitter.com/OSCvH9ckI7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
#ICYMI - Precigen provides 2020 clinical milestones during#JPM20 http://bit.ly/30qy4ua pic.twitter.com/Jm5QcumvYw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
#ICYMI - Check out Precigen's latest clinical and partnered pipeline presented at#JPM20 https://bit.ly/30qy4ua pic.twitter.com/JwtMsC8KUh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
#ICYMI - Check out Precigen's preclinical pipeline presented at#JPM20 https://bit.ly/30qy4ua pic.twitter.com/JExJ9yigkD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
Join Dr. Helen Sabzevari, President and CEO of Precigen, at
#JPM20 for her presentation on Precigen’s progress and a 2020 look ahead.#GeneTherapy#CellTherapy#Immunotherapy#Biotech#Maryland$XON https://bit.ly/2QMuOWK pic.twitter.com/dKVxJGUkt4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
Today, ARM released a report by Marwood Group illustrating the potential for
#celltherapy &#genetherapy to provide cost savings. In#sicklecell#SCD,#hemophilia A, and multiple myeloma, this represents an aggregate cost savings of $33B+ over ten years: http://bit.ly/2sbkqhB pic.twitter.com/oSsCyCXDfw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
Triple-Gene to highlight advantages of its multigenic approach for treatment of
#heartfailure at#BiotechShowcase on January 15th, 2020 at 11:30AM PT at the Hilton San Francisco Union Square. Read more here: http://ow.ly/Aof250xR5IF#cardiovasculardisease#genetherapy$XONpic.twitter.com/ftEX8ZHm1s
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
Just four days after Germantown's Intrexon Corp. made public plans to rebrand as Precigen, its subsidiary by the same name has secured a coveted regulatory designation for its blood cancer treatment.https://www.bizjournals.com/washington/news/2020/01/06/intrexon-will-take-the-name-of-its-subsidiary-that.html?ana=TRUEANTHEMTWT_WA&taid=5e13db2fb19b7e000192e7b5&utm_campaign=trueAnthem%3A+Trending+Content&utm_medium=trueAnthem&utm_source=twitter …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meredith Fensom proslijedio/la je Tweet
#Precigen receives first regulatory designation for PRGN-3006 UltraCAR-T#OrphanDrugDesignation#immunotherapy#biotech https://prn.to/2ZThUcc pic.twitter.com/4TuSU92eD3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.